Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation

  • Nicolas Arlicot
  • Andrew Katsifis
  • Lucette Garreau
  • Filomena Mattner
  • Jackie Vergote
  • Stéphanie Duval
  • Isabelle Kousignian
  • Sylvie Bodard
  • Denis Guilloteau
  • Sylvie Chalon
Erratum

DOI: 10.1007/s00259-008-0882-2

Cite this article as:
Arlicot, N., Katsifis, A., Garreau, L. et al. Eur J Nucl Med Mol Imaging (2008) 35: 2341. doi:10.1007/s00259-008-0882-2

Erratum to: Eur J Nucl Med Mol Imaging

DOI 10.1007/s00259-008-0834-x

Isabelle Kousignian, Inserm U930, Université François Rabelais, Tours, France also participated in this work. The complete list of authors is as follows:

Nicolas Arlicot1,2,3, Andrew Katsifis4, Lucette Garreau1,2, Filomena Mattner4, Jackie Vergote1,2, Stéphanie Duval1,2,3, Isabelle Kousignian1,2, Sylvie Bodard1,2, Denis Guilloteau1,2,3, Sylvie Chalon1,2,3

1Inserm, U930, Tours, F-37000 France

2Université François Rabelais, Tours, F-37000 France

3CHRU de Tours, Tours, F-37000 France

4Radiopharmaceuticals Research Institute, Australian Nuclear Science and Technology Organisation, Sydney, Australia”

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Nicolas Arlicot
    • 1
    • 2
    • 3
  • Andrew Katsifis
    • 4
  • Lucette Garreau
    • 1
    • 2
  • Filomena Mattner
    • 4
  • Jackie Vergote
    • 1
    • 2
  • Stéphanie Duval
    • 1
    • 2
    • 3
  • Isabelle Kousignian
    • 1
    • 2
  • Sylvie Bodard
    • 1
    • 2
  • Denis Guilloteau
    • 1
    • 2
    • 3
  • Sylvie Chalon
    • 1
    • 2
    • 3
  1. 1.Inserm, U930ToursFrance
  2. 2.Université François RabelaisToursFrance
  3. 3.CHRU de ToursToursFrance
  4. 4.Radiopharmaceuticals Research InstituteAustralian Nuclear Science and Technology OrganisationSydneyAustralia

Personalised recommendations